Safety test of a supplement, 5-aminolevulinic acid phosphate with sodium ferrous citrate, in diabetic patients treated with oral hypoglycemic agents

Functional Foods in Health and Disease

Volumn 4, Issue 9, 2014, Pages 415-428

  Yamashita, Naohide ^a   Watanabe, Atai ^a   Kondo, Hikaru ^b   Kawata, Satofumi ^b   Tanaka, Tohru ^b   Nakajima, Motowo ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SBI Pharmaceuticals Co   (Japan)

Author keywords

5 aminolevulinic acid (5 ALA); Fasting blood glucose (FBG); Hemoglobin A1c (HbA1c); Oral hypoglycemic agent (OHA); Sodium ferrous citrate (SFC); Type 2 diabetes

Indexed keywords

EID: 84969401198     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v4i9.151     Document Type: Article

References (29)

1. Ministry of Health, Labour and Welfare of Japan, National Health and Nutrition Survey 2007. http://www.mhlw.go.jp/bunya/kenkou/eiyou09/01.html.
2. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140.
3. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2009; 94: 311-321.
4. American Diabetes Association, Living with Diabetes, Treatment and Care, 2009. http://www.diabetes.org/living-with-diabetes/treatment-and-care/
5. Cerda C. Bruguera M. Pares A. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J Gastroenterol 2013; 19:5381-4.
6. Licata A. Macaluso FS. Craxi A. Herbal hepatotoxicity: a hidden epidemic. Inter Emergen Med 2013; 8:13-22.
7. Martin DJ. Partridge BJ. Shields W. Hepatotoxicity associated with the dietary supplement N.O.-XPLODE. Ann Intern Med 2013; 159:503-4.
8. Kuehn BM. Dietary supplement linked to cases of acute hepatitis. JAMA 2013; 310:1784.
9. Bunchorntavakul C. Reddy KR. Herbal and dietary supplement hepatotoxicity. AlimentPharmacol Therapeut 2013; 37:3-17.
10. Patel DN. Low WL. Tan LL. Tan MM. Zhang Q. Low MY. Chan CL. Koh HL. Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009. Clin Toxicol 2012; 50:481-9.
11. Fujioka K. Yu Y. Vomiting from multivitamins: a potential drug interaction. Greenway F. Am J Therapeut 2011; 18:453-7.
12. Rodriguez BL, Curb JD, Davis J, Shintani T, Perez MH, Apau-Ludlum N, Johnson C. Harrigan RC. Use of the dietary supplement 5-aminiolevulinic Acid (5-ALA) and its relationship with glucose levels and hemoglobin A1c among individuals with prediabetes. Clin Translation Sci 2012; 5: 314-320.
13. Higashikawa F, Noda M, Awaya T, Tanaka T, Sugiyama M. 5-aminolevulinic acid, a precursor of heme, reduces both fasting and postprandial glucose levels in mildly hyperglycemic subjects. Nutr 2013; 29: 1030-1036.
14. Maruyama K, Hagiya Y, Sugiyama Y, Tsuchiya K, Takahashi K, Abe F, Tabata K, Okura I, Nakajima M, Tanaka T, Ogura S. The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver. BMC Res Notes 2011; 4: 66.
15. Shimamura Y, Horinouchi I, Matsuda S, Tsuchiya K, Miyanari S, Kobayashi Y, Kuwahata M, Kido Y. Possibility of 5-aminolevulinic acid for nutritional supplement; Suppression of visceral fat accumulation in rats. In Aminolevulinic acid: Science, Technology and Application (Eds. Ichiro Okura, Tohru Tanaka) SBI ALApromo and Tokyo Institute of Technology Press, 2011, pp.109-116.
16. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010; 57: 751-62.
17. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC. The effect of oral antidiabetic agents on A1c levels: a systematic review and meta-analysis. Diabetes Care 2010; 33: 1859-64.
18. Hirst JA, Farmer AJ, Dyar A, Lung TW, Stevens RJ. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis. Diabetol 2013; 56: 973-84.
19. Inagaki N, Watada H, Murai M, Kagimura T, Gong Y, Patel S, Woerle HJ. Linagliptin provides effective, well-tolerated add-on therapy to pre-existing oral antidiabetic therapy over 1 year in Japanese patients with type 2 diabetes. Diabetes Obesity Metabol 2013; 15: 833-43.
20. Kadowaki T, Kondo K. Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus. Diabetes Obesity Metabol. 2013; 15: 810-818.
21. Cai L, Cai Y, Lu ZJ, Zhang Y, Liu P. The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. J Clin Pharm Therapeut 2012; 37: 386-398.
22. Umpierrez GE, Meneghini L. Reshaping diabetes care: the fundamental role of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists in clinical practice. Endocr Pract 2013; 19: 718-28
23. Post RE, Mainous III AG, King DE, Simpson KN. Dietary fiber for the treatment of type 2 diabetes mellitus: a meta-analysis. J Am Board Fam Med 2012; 25: 16-23;
24. Akilen R, Tsiami A, Devendra D, Robinson N. Cinnamon in glycaemic control: systematic review and meta analysis. Clin Nutr 2012; 31: 609-15.
25. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218-27.
26. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 2002; 25: 608-613.
27. Pastors JG, Franz MJ, Warshaw H, Daly A, Arnold MS. How effective is medical nutrition therapy in diabetes care? J Am Diet Assoc 2003; 103: 827-831.
28. Kushiyama A, Yoshida Y, Kikuchi T, Suzawa N, Yamamoto M, Tanaka K, Okayasu M, Tahara T, Takao T, Onishi Y, Kawazu S. Twenty-year trend of increasing obesity in young patients with poorly controlled type 2 diabetes at first diagnosis in urban Japan. J Diabetes Invest 2013; 4: 540-545.
29. Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 2013; 36: 1789-1796.